<DOC>
	<DOCNO>NCT00900029</DOCNO>
	<brief_summary>The objective study examine durability previous target wound closure , identify new test article-related adverse event , record new target wound closure , examine ongoing adverse event resolve subject participate HP 802-247-09-015 .</brief_summary>
	<brief_title>Safety Follow-Up HP 802-247-09-015</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<criteria>INCLUSION CRITERIA : Provide inform consent Willing comply protocol instruction , include allow study assessment . Subject randomize HP 80224709015 receive least one application test article , whether active placebo . Subject end participation HP 80224709015 virtue completing study , drop prior completion . Exclusion Criteria Subjects refuse provide write informed consent exclude trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Venous Leg Ulcer</keyword>
	<keyword>Venous Stasis Ulcer</keyword>
	<keyword>VLU</keyword>
	<keyword>VSU</keyword>
	<keyword>Leg Ulcer</keyword>
	<keyword>Leg Wound</keyword>
</DOC>